April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Apple: Dividend Growth Ahead, But a Near-Term Slide Likely
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Alpine Immune Sciences (ALPN) stock forecast for 2026
Updated: April 25, 2025 (06:23)
Sector: HealthcareThe share price of Alpine Immune Sciences, Inc. (ALPN) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Alpine Immune Sciences stocks, the 50-day moving average is the support level today.
For Alpine Immune Sciences stocks, the 200-day moving average is the support level today.
Are you interested in Alpine Immune Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alpine Immune Sciences stock price in 2026. How much will one Alpine Immune Sciences share be worth in 2026? Is it worth taking profit / loss on ALPN stock now or waiting? What are analysts' forecasts for Alpine Immune Sciences stock?
We forecast Alpine Immune Sciences stock performance using neural networks based on historical data on ALPN stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Alpine Immune Sciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Alpine Immune Sciences analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Alpine Immune Sciences, Inc. stock
The chart below shows the historical price of Alpine Immune Sciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ALPN stock price can be found in the table below.
Alpine Immune Sciences, Inc. Is a biopharmaceutical company. The company is focused on the discovery and development of protein immunotherapy for the treatment of cancer, autoimmune and inflammatory diseases. The Company’s scientific platform uses a directed evolutionary process to convert native immune system proteins from the immunoglobulin superfamily (IgSF) into multipurpose therapeutic drugs capable of modulating the human immune system. Its candidate products include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulant (ICOS) and differentiation cluster 28 (CD28) antagonist for the treatment of autoimmune and inflammatory diseases. His cancer program is ALPN-202, a conditional CD28 co-stimulator and dual checkpoint inhibitor for cancer treatment. ALPN-303 is a dual antagonist of B-cell cytokines for the treatment of B-cell mediated diseases.
Alpine Immune Sciences (ALPN) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 84.35 | 78.82 | 87.86 | 10.29 % |
| Feb | 85.03 | 77.41 | 87.89 | 11.92 % |
| Mar | 86.66 | 80.42 | 89.85 | 10.49 % |
| Apr | 83.33 | 78.93 | 87.73 | 10.03 % |
| May | 84.27 | 76.58 | 87.64 | 12.62 % |
| Jun | 96.40 | 90.23 | 106.12 | 14.97 % |
| Jul | 100.72 | 96.69 | 112.48 | 14.04 % |
| Aug | 110.07 | 105.49 | 121.34 | 13.06 % |
| Sep | 120.81 | 114.43 | 132.41 | 13.58 % |
| Oct | 136.47 | 126.20 | 145.20 | 13.08 % |
| Nov | 136.90 | 130.33 | 154.43 | 15.60 % |
| Dec | 146.76 | 129.85 | 162.02 | 19.86 % |
Alpine Immune Sciences information and performance
N/A
Market capitalization of the Alpine Immune Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALPN shares in the company outstanding by the market price of one share.
EBITDA of Alpine Immune Sciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Alpine Immune Sciences price target for 2026 by month
Target values for the price of one Alpine Immune Sciences share for Jan 2026.
In Jan, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 10.292% volatility is expected.
Pessimistic target level: 78.82
Optimistic target level: 87.86
Target values for the price of one Alpine Immune Sciences share for Feb 2026.
In Feb, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 11.919% volatility is expected.
Pessimistic target level: 77.41
Optimistic target level: 87.89
Target values for the price of one Alpine Immune Sciences share for Mar 2026.
In Mar, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 10.494% volatility is expected.
Pessimistic target level: 80.42
Optimistic target level: 89.85
Target values for the price of one Alpine Immune Sciences share for Apr 2026.
In Apr, the Negative dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 10.030% volatility is expected.
Pessimistic target level: 78.93
Optimistic target level: 87.73
Target values for the price of one Alpine Immune Sciences share for May 2026.
In May, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 12.615% volatility is expected.
Pessimistic target level: 76.58
Optimistic target level: 87.64
Target values for the price of one Alpine Immune Sciences share for Jun 2026.
In Jun, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 14.971% volatility is expected.
Pessimistic target level: 90.23
Optimistic target level: 106.12
Target values for the price of one Alpine Immune Sciences share for Jul 2026.
In Jul, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 14.040% volatility is expected.
Pessimistic target level: 96.69
Optimistic target level: 112.48
Target values for the price of one Alpine Immune Sciences share for Aug 2026.
In Aug, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 13.062% volatility is expected.
Pessimistic target level: 105.49
Optimistic target level: 121.34
Target values for the price of one Alpine Immune Sciences share for Sep 2026.
In Sep, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 13.577% volatility is expected.
Pessimistic target level: 114.43
Optimistic target level: 132.41
Target values for the price of one Alpine Immune Sciences share for Oct 2026.
In Oct, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 13.083% volatility is expected.
Pessimistic target level: 126.20
Optimistic target level: 145.20
Target values for the price of one Alpine Immune Sciences share for Nov 2026.
In Nov, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 15.603% volatility is expected.
Pessimistic target level: 130.33
Optimistic target level: 154.43
Target values for the price of one Alpine Immune Sciences share for Dec 2026.
In Dec, the Positive dynamics for Alpine Immune Sciences, Inc. shares will prevail with possible monthly volatility of 19.855% volatility is expected.
Pessimistic target level: 129.85
Optimistic target level: 162.02
